Valuation: Laboratorio Reig Jofre, S.A.

Market Cap 221M 255M 206M 190M 359M 24.26B 363M 2.43B 952M 12.13B 958M 937M 40.18B P/E 2026 *
13.6x
P/E 2027 * 22.7x
Enterprise Value 306M 353M 285M 262M 496M 33.54B 501M 3.37B 1.32B 16.76B 1.32B 1.3B 55.55B EV / Sales 2026 *
0.84x
EV / Sales 2027 * 0.77x
Free-Float
20.57%
Yield 2026 *
-
Yield 2027 * -
1 day-1.09%
1 week+0.74%
Current month+2.26%
1 month+1.12%
3 months-2.16%
6 months-1.45%
Current year+5.84%
1 week 2.64
Extreme 2.64
2.78
1 month 2.62
Extreme 2.62
2.78
Current year 2.32
Extreme 2.32
2.94
1 year 2.32
Extreme 2.32
3.35
3 years 2.15
Extreme 2.15
3.4
5 years 2.02
Extreme 2.02
5.3
10 years 1.87
Extreme 1.87
6.4
Manager TitleAgeSince
Chief Executive Officer 58 31/12/2005
Director of Finance/CFO - 19/12/2023
Chief Tech/Sci/R&D Officer - 31/12/2002
Director TitleAgeSince
Chairman - 30/12/2014
Director/Board Member 58 30/12/2014
Director/Board Member - 06/11/2017
Date Insider Type Main position Quantity % Market Cap.
01/12/22 Buy

Director

2,363 0.0030%
01/12/22 Buy

Director

1 0.0000%
01/12/22 Buy

Director

640 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%+0.74%-7.80%-0.73% 255M
-0.51%-8.60%+45.08%+148.21% 995B
+0.20%-4.42%+49.05%+50.81% 614B
-0.53%-7.37%+23.64%+65.03% 431B
+0.68%-2.77%+40.27%+34.96% 353B
+0.14%-4.45%+31.74%+39.89% 293B
-0.03%-9.27%+5.42%+7.61% 245B
-2.68%-8.29%-1.73%-42.05% 210B
+2.94%-0.78%+29.17%+60.32% 210B
+3.13%+0.69%+18.11%+71.90% 168B
Average +0.95%-4.44%+23.30%+43.59% 351.85B
Weighted average by Cap. +0.74%-5.89%+33.77%+70.63%

Financials

2026 *2027 *
Net sales 365M 420M 340M 313M 591M 39.97B 598M 4.01B 1.57B 19.98B 1.58B 1.54B 66.21B 392M 451M 365M 336M 635M 42.93B 642M 4.31B 1.68B 21.46B 1.69B 1.66B 71.11B
Net income 16.7M 19.23M 15.57M 14.3M 27.05M 1.83B 27.35M 184M 71.76M 915M 72.23M 70.64M 3.03B 9.5M 10.94M 8.86M 8.14M 15.39M 1.04B 15.56M 104M 40.82M 520M 41.09M 40.19M 1.72B
Net Debt 84.7M 97.55M 78.97M 72.55M 137M 9.28B 139M 931M 364M 4.64B 366M 358M 15.37B 78.7M 90.64M 73.38M 67.41M 127M 8.62B 129M 865M 338M 4.31B 340M 333M 14.28B
Logo Laboratorio Reig Jofre, S.A.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
Employees
1,400
Date Price Change Volume
04/08/26 2.720 -1.09% 9,630
03/08/26 €2.750 +3.38% 16,028
31/07/26 €2.660 +0.38% 6,164
30/07/26 €2.650 -1.12% 5,655
29/07/26 €2.680 -0.74% 16,014
Trader
-
Investor
Global
-
Quality
ESG MSCI
-

Annual profits - Rate of surprise